SMC
BHVN

S. Muoio & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

S. Muoio & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.87M Buy
18,980
+5,480
+41% +$812K 3.79% 6
2022
Q2 		$1.97M Buy
+13,500
New +$1.72M 2.8% 8

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

S. Muoio & Co's BHVN Position: Q3 2022 in Review

S. Muoio & Co increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 41% in Q3 2022, buying an estimated $812K and bringing the position to 18,980 shares worth $2.87M. The position accounts for 3.79% of the portfolio, ranked #6.

S. Muoio & Co first reported a position in BHVN in Q2 2022 and has held it in 2 quarters since. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • S. Muoio & Co held 18,980 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $2.87M as of Q3 2022.
  • S. Muoio & Co bought 5,480 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $812K.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 3.79% of S. Muoio & Co's portfolio in Q3 2022, its #6 holding.
  • S. Muoio & Co first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022 and has held it in 2 quarters since.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.